Bihan Hélène, Heidar Richard, Beloeuvre Aude, Allard Lucie, Ouedraogo Elise, Tatulashvili Sopio, Tandjaoui Yacine, Gaudry Stephane, Brillet Pierre-Yves, Cosson Emmanuel
Department of Endocrinology-Diabetology-Nutrition, CRNH-IdF, CINFO, AP-HP, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, Hôpital Avicenne, 125 route de Stalingrad, 93009, Bobigny, France.
Unit of Radiology, Avicenne Hospital, Bobigny, France.
Cardiovasc Diabetol. 2021 Jul 20;20(1):147. doi: 10.1186/s12933-021-01329-z.
Both visceral adipose tissue and epicardial adipose tissue (EAT) have pro-inflammatory properties. The former is associated with Coronavirus Disease 19 (COVID-19) severity. We aimed to investigate whether an association also exists for EAT.
We retrospectively measured EAT volume using computed tomography (CT) scans (semi-automatic software) of inpatients with COVID-19 and analyzed the correlation between EAT volume and anthropometric characteristics and comorbidities. We then analyzed the clinicobiological and radiological parameters associated with severe COVID-19 (O2 [Formula: see text] 6 l/min), intensive care unit (ICU) admission or death, and 25% or more CT lung involvement, which are three key indicators of COVID-19 severity.
We included 100 consecutive patients; 63% were men, mean age was 61.8 ± 16.2 years, 47% were obese, 54% had hypertension, 42% diabetes, and 17.2% a cardiovascular event history. Severe COVID-19 (n = 35, 35%) was associated with EAT volume (132 ± 62 vs 104 ± 40 cm, p = 0.02), age, ferritinemia, and 25% or more CT lung involvement. ICU admission or death (n = 14, 14%) was associated with EAT volume (153 ± 67 vs 108 ± 45 cm, p = 0.015), hypertension and 25% or more CT lung involvement. The association between EAT volume and severe COVID-19 remained after adjustment for sex, BMI, ferritinemia and lung involvement, but not after adjustment for age. Instead, the association between EAT volume and ICU admission or death remained after adjustment for all five of these parameters.
Our results suggest that measuring EAT volume on chest CT scans at hospital admission in patients diagnosed with COVID-19 might help to assess the risk of disease aggravation.
内脏脂肪组织和心外膜脂肪组织(EAT)均具有促炎特性。前者与冠状病毒病19(COVID-19)的严重程度相关。我们旨在研究EAT是否也存在这种关联。
我们回顾性地使用计算机断层扫描(CT)扫描(半自动软件)测量了COVID-19住院患者的EAT体积,并分析了EAT体积与人体测量特征及合并症之间的相关性。然后,我们分析了与严重COVID-19(氧流量[公式:见正文]<6升/分钟)、入住重症监护病房(ICU)或死亡以及CT肺部受累达25%或更多相关的临床生物学和放射学参数,这三个参数是COVID-19严重程度的关键指标。
我们纳入了100例连续患者;63%为男性,平均年龄为61.8±16.2岁,47%为肥胖患者,54%患有高血压,42%患有糖尿病,17.2%有心血管事件病史。严重COVID-19(n = 35,35%)与EAT体积(132±62 vs 104±40立方厘米,p = 0.02)、年龄、铁蛋白血症以及CT肺部受累达25%或更多相关。入住ICU或死亡(n = 14,14%)与EAT体积(153±67 vs 108±45立方厘米,p = 0.015)、高血压以及CT肺部受累达25%或更多相关。在对性别、体重指数、铁蛋白血症和肺部受累进行调整后,EAT体积与严重COVID-19之间的关联仍然存在,但在对年龄进行调整后则不存在。相反,在对所有这五个参数进行调整后,EAT体积与入住ICU或死亡之间的关联仍然存在。
我们的结果表明,在确诊为COVID-19的患者入院时通过胸部CT扫描测量EAT体积可能有助于评估疾病加重的风险。